NGM Biopharmaceuticals Inc (NGM) Ownership

5.09 ↓0.09 (-1.74%)
As of Market Close on January 27th, 2023.

Institutional Ownership

Column Group LLC is the biggest individual institutional holder of NGM Biopharmaceuticals Inc (NGM), owning a total of 18.1 million shares. Combined, the top 22 institutional holders of NGM own 57.30% of the company with a total of 46.8 million shares.

In the latest ownership report on September 30th 2022, the top 22 institutional holders increased their combined ownership of NGM by 5.9 million shares. 10 institutions bought 6,119,555 total additional shares and increased their ownership by an average of 21.15%. However 3 institutions sold 243,188 total shares and decreased their ownership by an average of 8.91%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of NGM Biopharmaceuticals increased by a net total of 5,876,367 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Column Group LLC22.192%0.000%18,136,73502022-09-30
FMR Inc5.291%109.858%4,324,2012,263,6682022-09-30
BlackRock Inc4.976%5.005%4,066,577193,8282022-09-30
Vanguard Group Inc4.771%14.577%3,899,297496,0892022-09-30
Avidity Partners Management LP2.200%0.000%1,798,1001,798,1002022-09-30
StepStone Group LLC1.925%0.000%1,573,35702022-09-30
Ponoi Management, LLC1.589%0.000%1,298,90802022-09-30
Ponoi II Management, LLC1.589%0.000%1,298,90802022-09-30
First Light Asset Management, LLC1.169%-15.880%955,505-180,3792022-09-30
Rubric Capital Management LP1.073%9.977%877,16179,5732022-09-30
State Street Corporation1.047%11.050%855,57585,1332022-09-30
Logos Global Management LP1.040%0.000%850,000850,0002022-09-30
Dimensional Fund Advisors, Inc.0.964%21.816%787,808141,0902022-09-30
Euclidean Capital LLC0.914%0.000%746,67402022-09-30
Nuveen Asset Management, LLC0.904%37.982%738,810203,3722022-09-30
Geode Capital Management, LLC0.902%1.194%737,3168,7022022-09-30
Morgan Stanley - Brokerage Accounts0.669%-7.470%547,059-44,1652022-09-30
EcoR1 Capital, LLC0.662%0.000%541,10802022-09-30
JPMorgan Chase & Co0.653%-3.374%533,897-18,6442022-09-30
Boxer Capital LLC0.612%0.000%500,00002022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Column Group LLC22.192%0.000%18,136,73502022-09-30
FMR Inc5.291%109.858%4,324,2012,263,6682022-09-30
BlackRock Inc4.976%5.005%4,066,577193,8282022-09-30
Vanguard Group Inc4.771%14.577%3,899,297496,0892022-09-30
Avidity Partners Management LP2.200%0.000%1,798,1001,798,1002022-09-30
StepStone Group LLC1.925%0.000%1,573,35702022-09-30
Point72 Asset Management, L.P.1.616%-58.869%1,320,662-1,890,2092022-06-30
Ponoi Management, LLC1.589%0.000%1,298,90802022-09-30
Ponoi II Management, LLC1.589%0.000%1,298,90802022-09-30
First Light Asset Management, LLC1.169%-15.880%955,505-180,3792022-09-30
Rubric Capital Management LP1.073%9.977%877,16179,5732022-09-30
State Street Corporation1.047%11.050%855,57585,1332022-09-30
Logos Global Management LP1.040%0.000%850,000850,0002022-09-30
Dimensional Fund Advisors, Inc.0.964%21.816%787,808141,0902022-09-30
Euclidean Capital LLC0.914%0.000%746,67402022-09-30
Nuveen Asset Management, LLC0.904%37.982%738,810203,3722022-09-30
Geode Capital Management, LLC0.902%1.194%737,3168,7022022-09-30
Morgan Stanley - Brokerage Accounts0.669%-7.470%547,059-44,1652022-09-30
EcoR1 Capital, LLC0.662%0.000%541,10802022-09-30
JPMorgan Chase & Co0.653%-3.374%533,897-18,6442022-09-30
Boxer Capital LLC0.612%0.000%500,00002022-09-30
Millennium Management LLC0.540%5.764%441,47524,0592022-06-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of NGM Biopharmaceuticals Inc (NGM), owning a total of 1.3 million shares. Combined, the top 28 mutual fund holders of NGM own 15.76% of the company with a total of 12.9 million shares.

In the latest ownership report on December 30th 2022, the top 28 fund holders increased their combined ownership of NGM by 8 thousand shares. 1 funds bought 228 total additional shares and increased their ownership by an average of 0.11%. However 2 funds sold 8,694 total shares and decreased their ownership by an average of 0.57%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding NGM Biopharmaceuticals decreased by a net total of -8,466 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Russell 2000 ETF1.130%-0.833%923,160-7,7502022-12-30
iShares Biotechnology ETF0.383%-0.301%313,063-9442022-12-30
iShares Russell 2000 Growth ETF0.248%0.113%202,3082282022-12-30
iShares Russell 2000 Value ETF0.200%0.000%163,07902022-12-30
Schwab US Small-Cap ETF™0.199%0.000%162,28502022-12-30

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv1.553%0.000%1,269,40302022-11-30
Vanguard Instl Ttl Stck Mkt Idx Tr1.553%20.889%1,269,403219,3472022-09-30
Vanguard Small Cap Index1.268%0.008%1,036,148862022-11-30
iShares Russell 2000 ETF1.130%-0.833%923,160-7,7502022-12-30
Fidelity® Series Small Cap Opps0.947%0.000%774,00002022-09-30
Vanguard Small Cap Value Index Inv0.879%0.678%718,3414,8362022-11-30
Fidelity Advisor® Biotechnology I0.844%0.000%690,00002022-09-30
Fidelity® Small Cap Growth0.838%87.320%685,183319,4002022-09-30
Fidelity® Small Cap Value0.795%0.000%650,00002022-09-30
Vanguard Extended Market Index Investor0.664%0.000%542,22402022-11-30
UTM IM GBP AXA Framlington Biotech0.467%0.000%381,87702022-11-30
Fidelity® Stock Selector Small Cap0.420%5.467%343,40017,8002022-09-30
TIAA-CREF Quant Small-Cap Equity Instl0.387%-1.492%316,340-4,7902022-11-30
Fidelity® Small Cap Index0.385%2.874%314,4398,7832022-10-31
iShares Biotechnology ETF0.383%-0.301%313,063-9442022-12-30
BlackRock Advantage Small Cap Core Instl0.329%0.000%269,10502022-11-30
Fidelity® Small Cap Stock0.319%5.933%260,70014,6002022-09-30
DFA US Micro Cap I0.299%0.000%244,28202022-11-30
Candriam Eqs L Biotech C USD Cap0.266%0.000%217,18702022-11-30
Fidelity Advisor® Small Cap I0.263%0.000%214,50002022-09-30
iShares Russell 2000 Growth ETF0.248%0.113%202,3082282022-12-30
CREF Stock R10.240%-5.267%196,484-10,9252022-11-30
JPMorgan Small Cap Value I0.224%-2.713%182,900-5,1002022-11-30
State St Russell Sm/Mid Cp® Indx NL Cl C0.223%0.000%182,00202022-11-30
Fidelity® Extended Market Index0.223%0.000%181,92502022-11-30
Vanguard Strategic Small-Cap Equity Inv0.216%0.000%176,367176,3672022-10-31
iShares Russell 2000 Value ETF0.200%0.000%163,07902022-12-30
Schwab US Small-Cap ETF™0.199%0.000%162,28502022-12-30

Discussions

Please log in or register to share your thoughts.

a

$NGM I can wait.

0 Like Report